The In-Vitro Diagnostics Market To Grow At A Higher Rate

Posted January 22, 2019 by sainath

The in-vitro diagnostics market size is expected to reach about $65 billion by 2022, significantly growing at a CAGR of around 4.5% during the forecast period.

The Business Research Company’s in-vitro diagnostics global market report, covers the year-on-year growth of the global in-vitro diagnostics market historic and forecast growth. It also includes chapters on the in-vitro diagnostics market trends, geographical analysis, and competitive landscape.

Order the report at:

The global in-vitro diagnostics market size is expected to reach about $65 billion by 2022, significantly growing at a CAGR of around 4.5% during the forecast period

In-Vitro Diagnostics Market Trends

The in-vitro diagnostics devices (or) equipment manufacturing market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics. This industry includes establishments that produce diagnostic devices used in microbiological diagnosis, hematological diagnosis, molecular diagnosis, point of care diagnosis and others.
Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space.

The global in-vitro diagnostics market is primarily driven by favorable government policies, rising awareness about such diseases, new health reforms and increasing economic growth.

Download a sample of the report:

The global in-vitro diagnostics market report covers the following regions under the geographical analysis section: Asia Pacific, Western Europe, North America, Middle East, Africa, South America, and Eastern Europe. Major countries under each of these regions are also covered under the country analysis chapters.
With increase in economic growth, health reforms and increased awareness in in-vitro diagnostics and growing aging population, the global in-vitro diagnostics market is expected to increase in potential and scope. TBRC’s report also covers the in-vitro diagnostics drivers and restraints in the market.

The global in-vitro diagnostics market’s segment shares in each geographic region are mentioned in the report, along with the historic and forecast growth rates for each segment presented visually with supporting reasons to justify the growth rates.
The top companies included in the global in-vitro diagnostics market report are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc), Abbott Laboratories Inc, Thermo Fisher Scientific Inc.

About The Business Research Company:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn:
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Sainath
Phone +442071930708
Business Address The Business Research Company,
Country United Kingdom
Categories Business , Medical , Services
Tags In-Vitro Diagnostics Market , Global In-Vitro Diagnostics Market , In-Vitro Diagnostics Industry , In-Vitro Diagnostics Market Size
Last Updated January 22, 2019